Updated on 28 August 2026
Multi-omics integration in genome-scale metabolic models
Tenured professor at Rīga Stradiņš University
Riga, Latvia
About
Genome-scale metabolic models enable comparison of healthy and diseased tissues, samples before and after therapy as well as other analyses where it is necessary to identify differences in metabolic network performance.
Another aspect is the genome-scale metabolic model based (in silico)development of combinatorial therapies.
The same can be done with cell culture and organoid samples.
Topic
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
In silico combinatorial therapy ranking
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Egils Stalidzans
Tenured professor at Rīga Stradiņš University
Riga, Latvia
Project cooperation
Integrated Translational & Functional Genomics Pipeline
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
Magdalena Krystkiewicz-Orzechowska
Assistant Professor at Department of Molecular Carcinogenesis, Medical University of Łódź
Łódź, Poland
Project cooperation
SPATIAL-RESIST: Spatial Functional Genomics of Therapy Resistance in Brain and Spine Tumors
- Consortium/Coordinator seeks Partners
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
Magdalena Krystkiewicz-Orzechowska
Assistant Professor at Department of Molecular Carcinogenesis, Medical University of Łódź
Łódź, Poland